Caseware UK (AP4) 2025.0.111 2025.0.111 2025-12-312025-12-31false2025-01-01falsecontinued to be that of an independent healthcare provider17true17false 06653668 2025-01-01 2025-12-31 06653668 2024-01-01 2024-12-31 06653668 2025-12-31 06653668 2024-12-31 06653668 c:Director1 2025-01-01 2025-12-31 06653668 d:PlantMachinery 2025-01-01 2025-12-31 06653668 d:PlantMachinery 2025-12-31 06653668 d:PlantMachinery 2024-12-31 06653668 d:PlantMachinery d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 06653668 d:FurnitureFittings 2025-01-01 2025-12-31 06653668 d:FurnitureFittings 2025-12-31 06653668 d:FurnitureFittings 2024-12-31 06653668 d:FurnitureFittings d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 06653668 d:ComputerEquipment 2025-01-01 2025-12-31 06653668 d:ComputerEquipment 2025-12-31 06653668 d:ComputerEquipment 2024-12-31 06653668 d:ComputerEquipment d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 06653668 d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 06653668 d:CurrentFinancialInstruments 2025-12-31 06653668 d:CurrentFinancialInstruments 2024-12-31 06653668 d:Non-currentFinancialInstruments 2025-12-31 06653668 d:Non-currentFinancialInstruments 2024-12-31 06653668 d:CurrentFinancialInstruments d:WithinOneYear 2025-12-31 06653668 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 06653668 d:Non-currentFinancialInstruments d:AfterOneYear 2025-12-31 06653668 d:Non-currentFinancialInstruments d:AfterOneYear 2024-12-31 06653668 d:ShareCapital 2025-12-31 06653668 d:ShareCapital 2024-12-31 06653668 d:SharePremium 2025-12-31 06653668 d:SharePremium 2024-12-31 06653668 d:RetainedEarningsAccumulatedLosses 2025-12-31 06653668 d:RetainedEarningsAccumulatedLosses 2024-12-31 06653668 c:FRS102 2025-01-01 2025-12-31 06653668 c:Audited 2025-01-01 2025-12-31 06653668 c:FullAccounts 2025-01-01 2025-12-31 06653668 c:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 06653668 d:WithinOneYear 2025-12-31 06653668 d:WithinOneYear 2024-12-31 06653668 d:BetweenOneFiveYears 2025-12-31 06653668 d:BetweenOneFiveYears 2024-12-31 06653668 d:MoreThanFiveYears 2025-12-31 06653668 d:MoreThanFiveYears 2024-12-31 06653668 c:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 06653668 2 2025-01-01 2025-12-31 06653668 15 2025-01-01 2025-12-31 06653668 17 2025-01-01 2025-12-31 06653668 e:PoundSterling 2025-01-01 2025-12-31 iso4217:GBP xbrli:pure

Registered number: 06653668










HTI ST. JAMES'S LIMITED T/A NOVA HEALTHCARE










FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2025

 
HTI ST. JAMES'S LIMITED T/A NOVA HEALTHCARE
REGISTERED NUMBER: 06653668

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 5 
60,539
205,340

  
60,539
205,340

Current assets
  

Debtors: amounts falling due within one year
 6 
1,179,722
1,250,525

Cash at bank and in hand
  
1,536,163
2,306,379

  
2,715,885
3,556,904

Creditors: amounts falling due within one year
 7 
(2,009,126)
(1,847,568)

Net current assets
  
 
 
706,759
 
 
1,709,336

Total assets less current liabilities
  
767,298
1,914,676

Creditors: amounts falling due after more than one year
 8 
-
(96,000)

Provisions for liabilities
  

Deferred tax
  
(9,000)
(45,000)

  
 
 
(9,000)
 
 
(45,000)

Net assets
  
758,298
1,773,676


Capital and reserves
  

Called up share capital 
  
142
142

Share premium account
  
499,958
499,958

Profit and loss account
  
258,198
1,273,576

  
758,298
1,773,676


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 14 August 2026.




W R Davis
Director
Page 1

 
HTI ST. JAMES'S LIMITED T/A NOVA HEALTHCARE
REGISTERED NUMBER: 06653668

STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2025


The notes on pages 3 to 9 form part of these financial statements.

Page 2

 
HTI ST. JAMES'S LIMITED T/A NOVA HEALTHCARE
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1.


General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Level 4 Bexley Wing, St James's Hospital, Beckett Street, Leeds, West Yorkshire, LS9 7TF.

The principal activity of the company continued to be that of an independent healthcare provider.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

HTI St James's contract with NHS England to provide gamma knife treatments to NHS patients has recently been extended to 30 September 2029, with an option to extend for a further two years.

The directors, having made due and careful enquiry, are of the opinion that the company has adequate working capital to execute its operations over the next 12 months. The directors, therefore, have made an informed judgement, at the time of approving the financial statements, that there is a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future.

As a result, the directors have continued to adopt the going concern basis of accounting in preparing the annual financial statements. 

Page 3

 
HTI ST. JAMES'S LIMITED T/A NOVA HEALTHCARE
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.3

Turnover

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the company has transferred the significant risks and rewards of ownership to the buyer;
the company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Operating leases: the company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.5

Leased assets: the company as lessee

Assets obtained under hire purchase contracts and finance leases are capitalised as tangible fixed assets. Assets acquired by finance lease are depreciated over the shorter of the lease term and their useful lives. Assets acquired by hire purchase are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to profit or loss so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.

 
2.6

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 4

 
HTI ST. JAMES'S LIMITED T/A NOVA HEALTHCARE
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.7

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.8

Pensions

Defined contribution pension plan

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the company in independently administered funds.

 
2.9

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


 
2.10

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 5

 
HTI ST. JAMES'S LIMITED T/A NOVA HEALTHCARE
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)


2.10
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
20%
Fixtures and fittings
-
33%
Computer equipment
-
33%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.11

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.

Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.12

Financial instruments

The company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's Statement of Financial Position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference
Page 6

 
HTI ST. JAMES'S LIMITED T/A NOVA HEALTHCARE
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)


2.12
Financial instruments (continued)

between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

 
2.13

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Judgements in applying accounting policies and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.


4.


Employees

The average monthly number of employees, including directors, during the year was 17 (2024 - 17).

Page 7

 
HTI ST. JAMES'S LIMITED T/A NOVA HEALTHCARE
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

5.


Tangible fixed assets


Plant and machinery
Fixtures and fittings
Computer equipment
Total

£
£
£
£



Cost or valuation


At 1 January 2025
5,732,826
140,886
109,354
5,983,066


Additions
1,900
-
-
1,900



At 31 December 2025

5,734,726
140,886
109,354
5,984,966



Depreciation


At 1 January 2025
5,534,498
134,690
108,538
5,777,726


Charge for the year on owned assets
144,000
2,190
511
146,701



At 31 December 2025

5,678,498
136,880
109,049
5,924,427



Net book value



At 31 December 2025
56,228
4,006
305
60,539



At 31 December 2024
198,328
6,196
816
205,340


6.


Debtors

2025
2024
£
£


Trade debtors
713,213
900,920

Other debtors
13,832
3,035

Prepayments and accrued income
452,677
346,570

1,179,722
1,250,525


Page 8

 
HTI ST. JAMES'S LIMITED T/A NOVA HEALTHCARE
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

7.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
1,014,489
328,200

Corporation tax
56,748
473,166

Other taxation and social security
14,357
6,454

Obligations under finance lease and hire purchase contracts
96,000
144,000

Other creditors
6,207
2,986

Accruals and deferred income
821,325
892,762

2,009,126
1,847,568



8.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Net obligations under finance leases and hire purchase contracts
-
96,000

-
96,000



9.


Commitments under operating leases

At 31 December 2025 the company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2025
2024
£
£


Not later than 1 year
541,595
589,731

Later than 1 year and not later than 5 years
2,166,379
2,358,923

Later than 5 years
406,196
1,032,029

3,114,170
3,980,683


10.


Controlling party

The joint ultimate controlling parties of the company are M Green, R Gilden and W Davis by virtue of their shareholdings.


11.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2025 was unqualified.

The audit report was signed on 14 August 2026 by Susan Seaman BA FCA CIOT (Senior Statutory Auditor) on behalf of AAB Audit & Accountancy Limited.

Page 9